Merck Serono

Ablynx, Merck expand partnership

Wednesday, November 9, 2011 03:08 PM

Ablynx has further expanded its relationship with Merck Serono and entered into a third agreement to co-discover and co-develop Nanobodies against two targets in osteoarthritis. The companies will exploit the unique Nanobody features and will develop multi-specific products, which have extended half-lives.

More... »

Merck, Ono Pharmaceutical collaborate

Tuesday, October 4, 2011 01:33 PM

Merck Serono has signed two separate agreements with Ono Pharmaceutical, Osaka, Japan to strengthen its multiple sclerosis and cancer franchises.

More... »

Icon and Bristol-Myers Squibb build on strategic partnership, extending it to early-phase work

Monday, September 5, 2011 08:00 AM

Icon and Bristol-Myers Squibb (BMS) have inked a preferred-provider agreement for early-phase development. This constitutes the CRO’s second sizable agreement with BMS; in June 2010, the two formed a strategic partnership, with Icon focused on providing global support for the drug developer’s clinical development pipeline.

More... »

Icon acquires Firecrest Clinical, adding portal technology to boost site quality while reducing errors and costs

Monday, July 25, 2011 08:02 AM

As large pharmaceutical companies scrutinize the pack of mid- and top-tier CROs to determine who wins the coveted strategic-partnership agreements, there’s a mad scramble among CROs to differentiate themselves from one another and stand out as efficient, high quality, exciting and deserving.

More... »

Merck Serono changes R&D organizational structure

Thursday, July 7, 2011 02:02 PM

Merck Serono, a division of Merck of Darmstadt, Germany, is putting a new organizational structure for research and development into effect. Two dedicated groups, focusing on different stages of pharmaceutical innovation (pre- and post- proof-of-concept), will be created as a first step in redesigning Merck Serono's R&D model.

More... »

MS research funding awards given

Wednesday, July 6, 2011 10:13 AM

Merck Serono and Fast Forward announced the second group of recipients to receive funding designed to speed research advances in high potential areas of multiple sclerosis (MS) research.

More... »

Merck Serono Building Global R&D Center in Beijing

Thursday, December 10, 2009 07:49 AM

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, wants to strengthen its global research and development (R&D) capabilities by establishing a global R&D center in Beijing, China.

More... »